AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
SNDL Inc.
Video analysis: SNDL
All videosNo video analysis for this stock yet. Request one from our team.
News: SNDL
SNDL Sees Unusually Large Options Volume (NASDAQ:SNDL)
SNDL Inc. (NASDAQ: SNDL - Get Free Report) saw unusually large options trading on Tuesday. Investors acquired 4,741 call options on the stock. This is an increase of approximately 371% compared to the average volume of 1,007 call options. Wall Street Analyst Weigh In Several brokerages have issued reports on SNDL. Weiss Ratings raised shares of
SNDL Announces Successful Completion of EU-GMP Audit at Atholville Facility
EDMONTON, Alberta, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) today announced the successful completion of a European Union Good Manufacturing Practice ("EU-GMP") audit at its Atholville, New Brunswick cultivation facility. The successful audit reinforces SNDL's ability to participate in regulated international medical cannabis markets and reflects the Company's continued focus on quality, operational excellence, and regulatory compliance.
Should You Buy, Hold or Sell SNDL Stock Post Q4 Earnings Release?
Earlier this week, SNDL Inc. SNDL reported dismal second-quarter 2026 results, with earnings and sales missing consensus estimates.
SNDL Inc. Hits 52-Week Low On Weaker Q2 2026 Earnings
SNDL reported weaker Q2-2026 financial performance earlier this week with lower revenue YoY and a net loss. SNDL completed the restructuring of its US Skymint assets and is well-positioned to enter US THC markets upon rescheduling. The cannabis sector remains weak due to uncertainty; the DEA hearing to reschedule cannabis has no updates.
SNDL Inc. (SNDL) Q2 2026 Earnings Call Transcript
SNDL Inc. (SNDL) Q2 2026 Earnings Call Transcript
SNDL Q2 Earnings Call Highlights
SNDL NASDAQ: SNDL reported lower second-quarter revenue and gross profit as demand weakness across liquor and cannabis markets, cannabis-production ramp-up costs and promotional activity weighed on results. The company said it continued to generate positive operating cash flow and improved free cash flow year over year, while accelerating share repurchases and advancing a restructuring involving U.S. cannabis operator Parallel.
SNDL Inc. (SNDL) Reports Q2 Loss, Lags Revenue Estimates
SNDL Inc. (SNDL) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago.
SNDL Reports Second Quarter 2026 Financial and Operational Results
The Company Maintains Strong Liquidity, Accelerates Share Repurchases, and Completes Parallel Restructuring Milestone The Company Maintains Strong Liquidity, Accelerates Share Repurchases, and Completes Parallel Restructuring Milestone
Similar companies
-
Emergent BioSolutions Inc.
EBS
·
New York Stock Exchange
Compare
-
SIGA Technologies, Inc.
SIGA
·
NASDAQ
Compare
-
Aquestive Therapeutics, Inc.
AQST
·
NASDAQ
Compare
-
Corvus Pharmaceuticals, Inc.
CRVS
·
NASDAQ
Compare
-
Organogenesis Holdings Inc.
ORGO
·
NASDAQ
Compare
-
Akebia Therapeutics, Inc.
AKBA
·
NASDAQ
Compare